Solved] 1. Jack, an exogenous drug at receptor X has a 100 fold lower
IJMS, Free Full-Text
SOLVED: 9. Jack, an exogenous drug at receptor X has 100-fold lower affinity than the endogenous ligand and is a superagonist (150% of Emax). Jill, another exogenous drug at target X, has
Glycosidase-targeting small molecules for biological and therapeutic applications - Chemical Society Reviews (RSC Publishing) DOI:10.1039/D3CS00032J
Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma - ScienceDirect
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor
The P2Y2 receptor mediates terminal adipocyte differentiation and insulin resistance: Evidence for a dual G-protein coupling mode - Journal of Biological Chemistry
Frontiers Cytosolic DNA sensors and glial responses to endogenous DNA
Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics
SOLVED: 9. Jack, an exogenous drug at receptor X has 100-fold lower affinity than the endogenous ligand and is a superagonist (150% of Emax). Jill, another exogenous drug at target X, has
SOLVED: 9. Jack, an exogenous drug at receptor X has 100-fold lower affinity than the endogenous ligand and is a superagonist (150% of Emax). Jill, another exogenous drug at target X, has